MCKENZIE DIANA (CIK 1754648) reported 15 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy MET (587 shares), Buy MET (169 shares), Buy MET (721 shares), Buy MET (189 shares), Buy MET (639 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | METLIFE INC (MET) | Director | Buy | 587 | $51,304 |
| 2026-06-11 | METLIFE INC (MET) | Director | Buy | 169 | $14,461 |
| 2026-04-03 | METLIFE INC (MET) | Director | Buy | 721 | $51,314 |
| 2026-03-12 | METLIFE INC (MET) | Director | Buy | 189 | $13,343 |
| 2026-01-06 | METLIFE INC (MET) | Director | Buy | 639 | $51,324 |
| 2025-12-11 | METLIFE INC (MET) | Director | Buy | 166 | $12,918 |
| 2025-10-03 | METLIFE INC (MET) | Director | Buy | 534 | $43,751 |
| 2025-09-11 | METLIFE INC (MET) | Director | Buy | 158 | $12,528 |
| 2025-06-20 | METLIFE INC (MET) | Director | Buy | 562 | $43,752 |
| 2025-06-12 | METLIFE INC (MET) | Director | Buy | 153 | $12,153 |
| 2025-05-30 | agilon health, inc. (AGL) | Director | Buy | 78,724 | $0 |
| 2025-05-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | Buy | 796 | $0 |
| 2025-05-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | Sell | 1,001 | $0 |
| 2025-04-03 | METLIFE INC (MET) | Director | Buy | 540 | $43,826 |
| 2025-03-13 | METLIFE INC (MET) | Director | Buy | 144 | $11,297 |
Source: SEC Form 4 filings · as of 2026-06-18